BIOLASE Inc news

   Watch this stock
Showing stories 1 - 10 of about 104   

Articles published

BIOL 2.10 -0.08 (-3.46%)
price chart
Healthcare Stocks In The Spotlight: BIOLASE, (NASDAQ:BIOL), AmSurg ...
BIOLASE, Inc. (NASDAQ:BIOL)'s shares picked up 5.85%, and closed at $2.17, during the last trading session, soon after the news release that a medical technology company, introduced dentistry's first-ever Practice Growth Guarantee with the launch of ...
Small Caps Attracting Some Extra Attention - Servicesource International ...  Wall Street Observer
Share Price of Biolase, Inc. Rally 5.34%
Shares of Biolase, Inc. (NASDAQ:BIOL) appreciated by 5.34% during the past week but lost 15.23% on a 4-week basis. The shares have outperformed the S&P 500 by 5.63% in the past week but underperformed the index by 19.64% in the last 4 weeks.
BIOLASE Inc Short Interest Update
The short interest in BIOLASE Inc (NASDAQ:BIOL) has declined from 3,232,700 on January 30,2015 to 3,156,728 on February 13,2015.
Oracle Partners Decisively Wins Shareholder Litigation Against Biolase, Inc.
GREENWICH, Conn., Jun 13, 2014 (BUSINESS WIRE) -- Oracle Partners, L.P. ("Oracle Partners"), Biolase, Inc.
Related articles »  
Form 8-K BIOLASE, INC For: Jan 31
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Biolase, Inc. (NASDAQ:BIOL) Update: BIOLASE names David Dreyer CFO
Biolase, Inc. (NASDAQ:BIOL) Updated based on the information released on Monday, Mar 2nd, BIOLASE names David Dreyer CFO.
Oracle Partners Announces Its Proxy Contest Against Biolase, Inc.
GREENWICH, Conn., March 11, 2014 /PRNewswire/ -- Oracle Partners, L.P. ("Oracle"), Biolase, Inc.'s ("Biolase" or the "Company") (Nasdaq: BIOL) largest shareholder, announces its nomination of four independent directors for election to the Biolase Board ...
Related articles »  
BIOLASE Inc (BIOL): Biolase: Management's Statements At Odds With The Facts
Management of Biolase (NASDAQ:BIOL) has repeatedly tried to mask bad news through the use of euphemistic and creative wording in disclosures and press releases.
Related articles »  
BIOLASE Inc (BIOL): Biolase: What Will Happen Next ?
Two days ago I highlighted an ongoing plunge that had already begun at Biolase (NASDAQ:BIOL). Prior to my article, the shares had already dropped by 50% in a few days due to the markets' concern over Biolase's solvency and an upcoming financing.
Related articles »  
Share Price of BIOLASE Inc Drops by -11.55%
BIOLASE Inc (NASDAQ:BIOL) has lost 11.55% during the past week and dropped 11.55% in the past 4 weeks. The shares are however, marginally negative as compared to the S&P 500 for the past week with a loss of 13.31%.